Kuipers A, Balasko M, Petervari E, Koller A, Brunner S, Moll G
Neurotherapeutics. 2021; 18(4):2737-2752.
PMID: 34859381
PMC: 8804135.
DOI: 10.1007/s13311-021-01155-x.
Zavala-Tecuapetla C, Cuellar-Herrera M, Luna-Munguia H
Int J Mol Sci. 2020; 21(22).
PMID: 33202963
PMC: 7697405.
DOI: 10.3390/ijms21228573.
Loscher W, Ferland R, Ferraro T
Epilepsy Behav. 2017; 73:214-235.
PMID: 28651171
PMC: 5909069.
DOI: 10.1016/j.yebeh.2017.05.040.
Constantin S, Wray S
Endocrinology. 2016; 157(8):3197-212.
PMID: 27359210
PMC: 4967115.
DOI: 10.1210/en.2016-1064.
Kerr N, Holmes F, Hobson S, Vanderplank P, Leard A, Balthasar N
Mol Cell Neurosci. 2015; 68:258-71.
PMID: 26292267
PMC: 4604734.
DOI: 10.1016/j.mcn.2015.08.006.
Neuropeptides as targets for the development of anticonvulsant drugs.
Clynen E, Swijsen A, Raijmakers M, Hoogland G, Rigo J
Mol Neurobiol. 2014; 50(2):626-46.
PMID: 24705860
PMC: 4182642.
DOI: 10.1007/s12035-014-8669-x.
Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.
Gygax M, Klein B, White H, Kim M, Galanopoulou A
Epilepsy Res. 2013; 108(1):98-108.
PMID: 24252685
PMC: 3872256.
DOI: 10.1016/j.eplepsyres.2013.10.015.
Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.
Einstein E, Asaka Y, Yeckel M, Higley M, Picciotto M
Eur J Neurosci. 2013; 37(9):1541-9.
PMID: 23387435
PMC: 3648588.
DOI: 10.1111/ejn.12151.
Galanin receptors and ligands.
Webling K, Runesson J, Bartfai T, Langel U
Front Endocrinol (Lausanne). 2012; 3:146.
PMID: 23233848
PMC: 3516677.
DOI: 10.3389/fendo.2012.00146.
Galanin negatively modulates opiate withdrawal via galanin receptor 1.
Holmes F, Armenaki A, Iismaa T, Einstein E, Shine J, Picciotto M
Psychopharmacology (Berl). 2011; 220(3):619-25.
PMID: 21969124
PMC: 3324978.
DOI: 10.1007/s00213-011-2515-x.
Neuroprotective role for galanin in Alzheimer's disease.
Counts S, Perez S, Ginsberg S, Mufson E
Exp Suppl. 2011; 102:143-62.
PMID: 21299067
PMC: 3117305.
DOI: 10.1007/978-3-0346-0228-0_11.
Galanin and consummatory behavior: special relationship with dietary fat, alcohol and circulating lipids.
Barson J, Morganstern I, Leibowitz S
Exp Suppl. 2011; 102:87-111.
PMID: 21299064
PMC: 6724711.
DOI: 10.1007/978-3-0346-0228-0_8.
Galanin receptor 1 deletion exacerbates hippocampal neuronal loss after systemic kainate administration in mice.
Schauwecker P
PLoS One. 2010; 5(12):e15657.
PMID: 21179451
PMC: 3001489.
DOI: 10.1371/journal.pone.0015657.
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R
Proc Natl Acad Sci U S A. 2010; 107(34):15229-34.
PMID: 20660766
PMC: 2930524.
DOI: 10.1073/pnas.1008986107.
Narrowing critical regions and determining penetrance for selected 18q- phenotypes.
Cody J, Heard P, Crandall A, Carter E, Li J, Hardies L
Am J Med Genet A. 2009; 149A(7):1421-30.
PMID: 19533771
PMC: 5325704.
DOI: 10.1002/ajmg.a.32899.
Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1.
Mitsukawa K, Lu X, Bartfai T
Neuroscience. 2009; 160(4):837-46.
PMID: 19272414
PMC: 2673341.
DOI: 10.1016/j.neuroscience.2009.02.063.
Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice.
Lu X, Bartfai T
Naunyn Schmiedebergs Arch Pharmacol. 2009; 379(4):417-20.
PMID: 19159918
PMC: 2725758.
DOI: 10.1007/s00210-009-0394-z.
Variation in Galr1 expression determines susceptibility to exocitotoxin-induced cell death in mice.
Kong S, Lorenzana A, Deng Q, McNeill T, Schauwecker P
Genes Brain Behav. 2008; 7(5):587-98.
PMID: 18363852
PMC: 2836321.
DOI: 10.1111/j.1601-183X.2008.00395.x.
Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity.
Page A, Slattery J, Brierley S, Jacoby A, Blackshaw L
J Physiol. 2007; 583(Pt 2):675-84.
PMID: 17627995
PMC: 2277026.
DOI: 10.1113/jphysiol.2007.135939.
Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze.
Bailey K, Pavlova M, Rohde A, Hohmann J, Crawley J
Pharmacol Biochem Behav. 2007; 86(1):8-20.
PMID: 17257664
PMC: 1853242.
DOI: 10.1016/j.pbb.2006.11.024.